Virpax Pharmaceuticals, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 1 | -$1.53 | -$1.53 | -$1.53 |
| Q2 2024 | 1 | -$0.54 | -$0.54 | -$0.54 |
| Q3 2024 | 1 | -$0.27 | -$0.27 | -$0.27 |
Virpax Pharmaceuticals, Inc. Earnings Date And Information
Virpax Pharmaceuticals, Inc. last posted its earnings results on Thursday, November 14th, 2024. The company reported $-0.43 earnings per share for the quarter, topping analysts' consensus estimates of $-0.54 by $0.11. The company had revenue of 0 for the quarter and had revenue of 0 for the year. Virpax Pharmaceuticals, Inc. has generated $-13 earnings per share over the last year ($-12.97 diluted earnings per share) and currently has a price-to-earnings ratio of -0.25. Virpax Pharmaceuticals, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, March 26th, 2025 based on prior year's report dates.
Virpax Pharmaceuticals, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/14/2024 | Q3 2024 | -$0.54 | -$0.43 | 0.11 | $0 | $0 |
| 08/12/2024 | Q2 2024 | -$1.53 | -$1.75 | -0.22 | $0 | $0 |
| 05/13/2024 | Q1 2024 | -$2.75 | $0 | |||
| 03/26/2024 | Q4 2023 | -$2.70 | -$3.89 | -1.19 | $0 | |
| 12/07/2023 | Q3 2023 | -$5.12 | $0 | |||
| 08/14/2023 | Q2 2023 | -$2.66 | $0 | |||
| 05/12/2023 | Q1 2023 | -$1.19 | $0 | |||
| 03/22/2023 | Q4 2022 | -$2.45 | $0 | |||
| 11/09/2022 | Q3 2022 | -$0.45 | -$0.65 | -0.2 | $0 | |
| 08/15/2022 | Q2 2022 | -$0.44 | -$0.50 | -0.06 | $0 | |
| 05/16/2022 | Q1 2022 | -$0.44 | $0 | |||
| 03/31/2022 | Q4 2021 | -$0.62 | $0 | |||
| 11/15/2021 | Q3 2021 | -$0.53 | $0 | |||
| 08/09/2021 | Q2 2021 | -$0.47 | $0 | |||
| 05/17/2021 | Q1 2021 | -$0.54 | -$0.60 | -0.06 | $0 | |
| 03/31/2021 | Q4 2020 | -$0.16 | $0 | |||
| 09/30/2020 | Q3 2020 | -$0.38 | $0 | |||
| 06/30/2020 | Q2 2020 | -$0.26 | $0 | |||
| 03/31/2020 | Q1 2020 | -$0.13 | $0 | |||
| 12/31/2019 | Q4 2019 | -$0.14 | $0 |
Virpax Pharmaceuticals, Inc. Earnings: Frequently Asked Questions
-
When is Virpax Pharmaceuticals, Inc.'s earnings date?
Virpax Pharmaceuticals, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, March 26th, 2025 based off last year's report dates.
-
Did Virpax Pharmaceuticals, Inc. beat their earnings estimates last quarter?
In the previous quarter, Virpax Pharmaceuticals, Inc. (:VRPX) reported $-0.43 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.54 by $0.11.
-
How can I listen to Virpax Pharmaceuticals, Inc.'s earnings conference call?
The conference call for Virpax Pharmaceuticals, Inc.'s latest earnings report can be listened to online.
-
How can I read Virpax Pharmaceuticals, Inc.'s conference call transcript?
The conference call transcript for Virpax Pharmaceuticals, Inc.'s latest earnings report can be read online.
-
How much profit does Virpax Pharmaceuticals, Inc. generate each year?
Virpax Pharmaceuticals, Inc. (:VRPX) has a recorded net income of $0. Virpax Pharmaceuticals, Inc. has generated $-12.97 earnings per share over the last four quarters.
-
What is Virpax Pharmaceuticals, Inc.'s price-to-earnings ratio?
Virpax Pharmaceuticals, Inc. (:VRPX) has a price-to-earnings ratio of -0.25 and price/earnings-to-growth ratio is -0.01.
